SS Innovations International, Inc.
ssinnovations.comWhat Do They Do?
Sells surgical robotic systems, surgical instruments and accessories to hospitals and healthcare facilities.
10-K for FY2025, filed Mar 10, 2026We are a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical…View ↗
We generate revenues from the sale of the SSi Mantra. We offer our SSi Mantra through three selling models: (i) outright purchase, where…View ↗
The SSi Mantra is designed to enable surgeons to perform a wide range of surgical procedures including cardiovascular, thoracic, head and…View ↗
We offer a comprehensive suite of stapling, energy and core instrumentation for our surgical systems, under the brand name of SSi Mudra.View ↗
How Do They Make Money?
Hospitals can pay for systems upfront at delivery, in installments after an advance, or per procedure; customers regularly reorder instruments and accessories. Warranty income comes over its warranty period, while per-procedure systems also bring fixed lease payments and variable fees tied to procedures.
10-K for FY2025, filed Mar 10, 2026We generate revenues from the sale of the SSi Mantra. We offer our SSi Mantra through three selling models: (i) outright purchase, where…View ↗
In cases where the systems are installed on a pay-per-procedure basis, the Company earns revenue share which is a mix of fixed and variable…View ↗
Our customers place orders to replenish their supplies of instruments and accessories on a regular basis. New direct customers who purchase…View ↗
Payment Terms: Determination of payment terms, which may involve either a deferred payment arrangement or a one-time payment upon delivery…View ↗
Deferred Payment Model: For deferred payments, customers typically pay an advance amount before the dispatch of the system. The remaining…View ↗
The revenue attributable to the warranty is recognized over the period to which it relates. During the year ended December 31, 2025…View ↗
-
10-K for FY2025, filed Mar 10, 2026
FY2025 revenue by product or service ↗
$42.5M
-
10-K for FY2025, filed Mar 10, 2026
$42.5M ↗
| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
System sales
|
90%
FY2022: 97%
|
System sales, FY2025
$38.4M Sources
|
|
|
Instruments sale
Sold outright
|
7.5%
FY2022: 2.9%
|
Instruments sale, FY2025
$3.2M Sources
|
Sold outright |
|
Warranty sale
Recurring
|
2.1% |
Warranty sale, FY2025
$877K Sources
|
Recurring |
|
Lease income
Recurring
|
0.2% |
Lease income, FY2025
$70.9K Sources
|
Recurring |
Who Are Their Customers?
Hospitals and healthcare facilities, including individual sites and integrated chains, buy systems directly through the company’s India sales team; outside India, sales go through distributors. Hospitals reorder instruments and accessories regularly.
10-K for FY2025, filed Mar 10, 2026We provide our systems and related devices through a direct sales organization in India and, outside of India, through an expanding…View ↗
Our direct sales organization is composed of a capital sales team of ten individuals, who are responsible for selling systems, and a…View ↗
Our customers place orders to replenish their supplies of instruments and accessories on a regular basis. New direct customers who purchase…View ↗
Do Revenues Turn Into Profits?
No. It lost $12.1M in FY2025.
10-K for FY2025, filed Mar 10, 2026
−$8.2MView ↗
10-K for FY2025, filed Mar 10, 2026
−$12.1MView ↗
10-K for FY2025, filed Mar 10, 2026
−$22.2MView ↗
How Are They Changing?
- Net income
-
Sources
10-Q for Q2 FY2026, filed Aug 13, 2026
−$2.7MView ↗
- ▲ +937% (Loss)
- vs −$256.7K in Q2 FY2025
-
Aug 26, 2026
Sarah Romano ceased serving as chief financial officer
The company said her departure was not related to financial reporting, controls, operations, policies or accounting practices.
Sources
8-K, filed Aug 26, 2026
Effective August 21, 2026, Sarah Romano is no longer serving as Chief Financial Officer of the Company. Ms. Romano's departure was not the…View ↗
-
Jul 14, 2026
Sarah Romano appointed chief financial officer
Sources
8-K, filed Jul 14, 2026
On July 14, 2026, we issued a press release announcing the appointment of Sarah M. Romano as the Company’s new Chief Financial Officer…View ↗
From aesthetics to surgical robotics
Earlier business plans centered on an autonomous medical robot for skin-resurfacing treatments; the latest report focuses on a surgical robot for hospital operating rooms and related instruments.
10-K for FY2022, filed Mar 31, 2023 10-K for FY2025, filed Mar 10, 2026We are a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical…View ↗
The SSi Mantra is designed to enable surgeons to perform a wide range of surgical procedures including cardiovascular, thoracic, head and…View ↗
We offer a comprehensive suite of stapling, energy and core instrumentation for our surgical systems, under the brand name of SSi Mudra.View ↗
Who Do They Compete With?
Competes with Intuitive Surgical, Asensus Surgical, avateramedical, CMR Surgical, Johnson & Johnson, Medicaroid, Medrobotics, Medtronic, meerecompany, Olympus, Samsung Electronics, Shandong Weigao Group Medical Polymer, Shanghai Microport Medbot (Group), and Titan Medical
10-K for FY2025, filed Mar 10, 2026We compete with a number of U.S. and foreign companies that have developed and currently manufacture and market products in the field of…View ↗
Loading...
